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Phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2)i s
needed for retrograde membrane trafﬁcking from lysoso-
mal and late endosomal compartments and its synthesis is
tightly regulated. But how cells regulate PtdIns(3,5)P2
synthesis—for example, in response to hyperosmotic
shock—remains unexplained. A paper from the Weisman
group gives the most complete picture so far of a multi-
protein complex that controls PtdIns(3,5)P2 synthesis and
explains how a VAC14 mutation functionally impairs the
scaffold protein at the heart of the complex and causes a
neurodegenerative condition in mice.
Since phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) was
discovered a decade ago (Dove et al, 1997), it has become clear that
it is a ubiquitous eukaryote phosphoinositide of very low abun-
dance. PtdIns(3,5)P2 probably has multiple functions—the best
characterised of which is support, and probably regulation, of
retrograde membrane trafﬁcking from lysosomal and late endoso-
mal compartments to the Golgi complex (Dove et al, 2004; Efe et al,
2005; Michell et al, 2006; Shisheva, 2008). Genetic loss or malfunc-
tion of several proteins essential to PtdIns(3,5)P2 function is
deleterious both in yeast and animals (see Jin et al (2008) for
references). Only recently have the ﬁrst real hints about
how cellular PtdIns(3,5)P2 levels are regulated—for example,
how is synthesis stimulated by hyperosmotic shock—begun to
emerge, and this is the problem addressed by this study (Jin et al,
2008).
The PtdIns3P 5-kinases that make PtdIns(3,5)P2 are usually
named Fab1p (as in yeast) or PIKfyve (in mammals). FAB1 mutants
belong to a class of yeast mutants that have enlarged vacuoles and
increased stress sensitivity, and well-regulated PtdIns(3,5)P2 synth-
esis in vivo also needs the products of two other members of this
gene group—Vac14p (alias ArPIKfyve in mice) and Vac7p. Proper
control of PtdIns(3,5)P2 synthesis also requires two other proteins
involved in PtdIns(3,5)P2 function: the PtdIns(3,5)P2 5-phosphatase
Fig4p (Sac3 in mouse), to permit effective PtdIns(3,5)P2 synthesis;
and the PtdIns(3,5)P2 effector protein Atg18p, to prevent
PtdIns(3,5)P2 synthesis from going into overdrive (for references,
see Efe et al, 2005; Michell et al, 2006). This paper starts by showing
that a mutation near the N terminus of Vac14p causes the defects
seen in homozygous ingls mice, which are small and have mal-
formed nervous systems and a short lifespan (Bronson et al, 2004).
The central feature of the paper is a new model of the molecular
conﬁguration of Vac14p, which the Weisman group earlier
showed to be essential for mice to develop a nervous system that
can carry them beyond birth (Zhang et al, 2007). There were earlier
suggestions that Vac14p contained HEAT domains (Dove et al,
2002), and this paper’s structural modelling uses many Vac14p
sequences to predict that Vac14p/ArPIKfyve proteins are con-
structed entirely of HEAT domains, with at least 15 widely con-
served. This suggests that Vac14p probably functions as the scaffold
of a multi-protein complex. This study uses a combination of
co-immunoprecipitation, yeast two-hybrid, imaging and co-sedi-
mentation studies to show that Fab1p, Vac7p, Fig4p and some
Atg18p join with Vac14p to form a complex at the vacuole mem-
brane. Others have suggested some of these associations before
(Botelho et al, 2008; Sbrissa et al, 2008), but they did not envisage
such a diverse assemblage.
Mutations were used to characterise the complex further. When
the ingls mutation (which is in HEAT domain 4) was put into yeast
VAC14, the resulting Vac14p mutant only bound Fig4p—which
associated with its C-terminal half—and the cells failed to make
large amounts of PtdIns(3,5)P2 when hyper-osmotically stressed.
Another VAC14 mutant showing poor Fab1p activation had defects
in HEAT domains 2 and 3: its Vac7p and Atg18p interactions
were defective, but it interacted with Fig4p normally. Mutating a
chaperone-like domain close to the centre of the FAB1 sequence
(see Michell et al, 2006) prevented both the Fab1p–Vac14p inter-
action and localisation of Fab1p, Vac14p and Fig4p to the vacuole
membrane.
These results suggest the existence of a complex of the type
shown in Figure 1. Vac14p, maybe as a dimer, is the scaffold. Vac7p
and Atg18p bind close to its N terminus, Fab1p somewhat more
centrally, and Fig4p somewhere on the C-terminal half of Vac14p.
But much still remains to be worked out––what are the details of the
interactions between the proteins in the complex, how do these
interactions control the kinase activity of Fab1p, what interactions
hold the complex at the vacuole membrane and how do external
inﬂuences such as osmotic perturbations control PtdIns(3,5)P2
synthesis by this complex?
Figure 1 A schematic representation of the PtdIns(3,5)P2-synthe-
sising complex of yeast at the vacuole membrane, as elucidated by
Jin et al (2008). PtdIns(3,5)P2 is made by Fab1p, which is anchored
to Vac14p, as are the interacting Fab1p regulators Vac7p, Fig4p and
Atg18p.
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